Antiproliferative effect of echinacoside on rat pulmonary artery smooth muscle cells under hypoxia

Journal of Pharmacological Sciences

Volumn 126, Issue 2, 2014, Pages 155-163

  Gai, Xiang Yun ^a   Tang, Feng ^b   Ma, Jing ^c   Zeng, Ke Wu ^d   Wang, Sheng Lan ^b   Wang, Ya Ping ^b   Wuren, Ta Na ^b   Lu, Dian Xiang ^b   Zhou, Yi ^a,b   Ge, Ri Li ^a,b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b QINGHAI UNIVERSITY   (China)

^c Department of Endemic Diseases Institute for Endemic Diseases Prevention and Control of Qinghai Province   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Apoptosis; High altitude; Proliferation of rat pulmonary artery smooth muscle cell (pasmc); Pulmonary arterial hypertension; Tibetan herb

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; ECHINACOSIDE; FAS ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN BAX; PROTEIN BCL 2; BAX PROTEIN, RAT; GLYCOSIDE; HIF1A PROTEIN, RAT; TNFRSF6 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTERY MUSCLE; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MTS ASSAY; NONHUMAN; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; CELL CULTURE; CELL HYPOXIA; CHEMICAL PHENOMENA; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE; WISTAR RAT;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL HYPOXIA; CELL PROLIFERATION; CELLS, CULTURED; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GLYCOSIDES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEINS C-BCL-2; PULMONARY ARTERY; RATS, WISTAR; VASCULAR REMODELING;

EID: 84909966017     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.14072FP     Document Type: Article

References (36)

1. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351:1425-1436.
2. Tuder RM. Pathology of pulmonary arterial hypertension. Semin Respir Crit Care Med. 2009;30:376-385.
3. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336:111-117.
4. Abe K, Toba M, Alzoubi A, Ito M, Fagan KA, Cool CD, et al. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension. Circulation. 2010;121:2747-2754.
5. McMurtry MS, Archer SL, Altieri DC, Bonnet S, Haromy A, Harry G, et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest. 2005;115:1479-1491.
6. Malhotra R, Lin Z, Vincenz C, Brosius FC. Hypoxia induces apoptosis via two independent pathways in Jurkat cells: differential regulation by glucose. Am J Physiol Cell Physiol. 2001; 281:1596-1603.
7. Suzuki YJ, Nagase H, Wong CM, Kumar SV, Jain V, Park AM, et al. Regulation of Bcl-xL expression in lung vascular smooth muscle. Am J Respir Cell Mol Biol. 2007;36:678-687.
8. Caretti A, Bianciardi P, Ronchi R, Fantacci M, Guazzi M, Samaja M, et al. Phosphodiesterase-5 inhibition abolishes neuron apoptosis induced by chronic hypoxia independently of hypoxia- inducible factor-1alpha signaling. Exp Biol Med (Maywood). 2008;233:1222-1230.
9. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet. 2003;361:1533-1544.
10. Cowan KN, Jones PL, Rabinovitch M. Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res. 1999;84:1223-1233.
11. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest. 2005;115:2811-2821.
12. Xing YX, Hu FZ, Dong Q, Peng M. Determination of echinacoside and acteoside in Tibetan herb Lagotis brevituba Maxim. Chin J Pharm Anal. 2012;32:1183-1185.
13. Zhao Q, Gao J, Li W, Cai D. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease. Brain Res. 2010;1346:224-236.
14. Chinese pharmacopeia commission. Chinese pharmacopoeia & national standards. Beijing: Chemical and Industrial Publisher. 1995.
15. Tu PF, Wang B, Deyama T, Zhang ZG, Lou ZC. Analysis of phenylethanoid glycosides of Herba Cistanchis by RP-HPLC. Acta Pharm Sin. 1997;32:294-300.
16. Yang X, Li F, Yang Y, Shen J, Zou R, Zhu P, et al. Efficacy and safety of echinacoside in a rat osteopenia model. Evid Based Complement Alternat Med. 2013;2013:1-10.
17. He WJ, Fang TH, Ma X, Zhang K, Ma ZZ, Tu PF. Echinacoside elicits endothelium-dependent relaxation in rat aortic rings via an NO-cGMP pathway. Planta Med. 2009;75:1400-1404.
18. Yu XM, Wang L, Li JF, Liu J, Li J, Wang W, et al. Wnt5a inhibits hypoxia-induced pulmonary arterial smooth muscle cell proliferation by downregulation of β-catenin. Am J Physiol Lung Cell Mol Physiol. 2013;304:103-111.
19. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
20. Kapuscinski J. DAPI: a DNA-specific fluorescent probe. Biotech Histochem. 1995;70:220-233.
21. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 2006;70:1469-1480.
22. Shan R, Chen L, Li X, Wu H, Liang Q, Tang X. Hypoxia promotes rabbit pulmonary artery smooth muscle cells proliferation through a 15-LOX-2 product 15(S)-hydroxyeicosatetraenoic acid. Prostaglandins Leukot Essent Fatty Acids. 2012;86:85-90.
23. Wang J, Juhaszova M, Rubin LJ, Yuan XJ. Hypoxia inhibits gene expression of voltage-gated K+ channel alpha subunits in pulmonary artery smooth muscle cells. J Clin Invest. 1997;100:2347-2353.
24. Krick S, Hänze J, Eul B, Savai R, Seay U, Grimminger F, et al. Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1alpha and an autocrine angiotensin system. FASEB J. 2005;19:857-859.
25. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J Clin Invest. 1999;103:691-696.
26. Wang YF, Tian H, Tang CS, Jin HF, Du JB. Nitric oxide modulates hypoxic pulmonary smooth muscle cell proliferation and apoptosis by regulating carbon monoxide pathway. Acta Pharmacol Sin. 2007;28:28-35.
27. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1-16.
28. Friesen C, Lubatschofski A, Glatting G, Debatin KM, Reske SN. Activation of intrinsic apoptotic pathway by Re-188 irradiation and paclitaxel in coronary artery smooth muscle cells. Q J Nucl Med Mol Imaging. 2008;52:289-295.
29. Mrabat H, Garg HG, Hales CA. Growth inhibition of bovine pulmonary artery smooth muscle cells following long-term heparin treatment. J Cell Physiol. 2009;221:603-608.
30. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13:1899-1911.
31. Antonsson B, Martinou JC. The Bcl-2 protein family. Exp Cell Res. 2000;256:50-57.
32. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275:1129-1132.
33. Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A. 1998;95:4997-5002.
34. Schinzel A, Kaufmann T, Schuler M, Martinalbo J, Grubb D, Borner C. Conformational control of Bax localization and apoptotic activity by Pro168. J Cell Biol. 2004;164:1021-1032.
35. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
36. Fukuo K, Hata S, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y, et al. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension. 1996;27(3 Pt 2):823-826.